EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of RP-HPLC Method for Estimation of Tofacitinib in Bulk Form

Dr. S. P. Kumbhar Dr. S. P. Kumbhar, Dr. S. S. Patil Dr. S. S. Patil, Omkar Gotmukle Omkar Gotmukle, N. B. Bhalke N. B. Bhalke, Dr. S. V. Garad Dr. S. V. Garad

International Journal of Science, Strategic Management and Technology · 17.06.2026 · 02 (06) · 1-16

DOI: 10.55041/ijsmt.v2i6.143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Science, Strategic Management and Technology, online erschienen am 17.06.2026. Verfasst von Dr. S. P. Kumbhar Dr. S. P. Kumbhar und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A simple, accurate, precise, and robust Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method was developed and validated for the quantitative estimation of Tofacitinib in bulk drug form. Chromatographic separation was achieved using a C18 column with a suitable mobile phase consisting of an aqueous buffer and organic solvent in optimized proportions. The analysis was carried out at an appropriate flow rate, and detection was performed using a UV detector at the selected wavelength. Tofacitinib exhibited a well-resolved peak with satisfactory retention time and peak symmetry. The developed method was validated according to International Council for Harmonisation (ICH) guidelines for various validation parameters including specificity, linearity, accuracy, precision, robustness, limit of detection (LOD), and limit of quantification (LOQ). The method demonstrated excellent linearity over the selected concentration range with a correlation coefficient close to unity. Recovery studies confirmed the accuracy of the method, while precision studies showed low relative standard deviation values, indicating good repeatability and intermediate precision. The robustness of the method was established by introducing small deliberate variations in chromatographic conditions without significantly affecting the results. The developed RP-HPLC method was found to be simple, reliable, cost-effective, and suitable for routine quality control analysis of Tofacitinib in bulk pharmaceutical materials.

Zitieren

APA

Kumbhar, D. S. P. K. D. S. P., Patil, D. S. S. P. D. S. S., Gotmukle, O. G. O., Bhalke, N. B. B. N. B., & Garad, D. S. V. G. D. S. V. (2026). Development and Validation of RP-HPLC Method for Estimation of Tofacitinib in Bulk Form. International Journal of Science, Strategic Management and Technology, 02(06), 1-16. https://doi.org/10.55041/ijsmt.v2i6.143

Vancouver

Kumbhar DSPKDSP, Patil DSSPDSS, Gotmukle OGO, Bhalke NBBNB, Garad DSVGDSV. Development and Validation of RP-HPLC Method for Estimation of Tofacitinib in Bulk Form. International Journal of Science, Strategic Management and Technology. 2026;02(06):1-16. doi:10.55041/ijsmt.v2i6.143

BibTeX
@article{Kumbhar2026,
  author = {Kumbhar, Dr. S. P. Kumbhar Dr. S. P. and Patil, Dr. S. S. Patil Dr. S. S. and Gotmukle, Omkar Gotmukle Omkar and Bhalke, N. B. Bhalke N. B. and Garad, Dr. S. V. Garad Dr. S. V.},
  title = {Development and Validation of RP-HPLC Method for Estimation of Tofacitinib in Bulk Form},
  journal = {International Journal of Science, Strategic Management and Technology},
  year = {2026},
  volume = {02},
  number = {06},
  pages = {1--16},
  doi = {10.55041/ijsmt.v2i6.143}
}
Kostenlos starten →